Connect with us


Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer – Science Magazine

Some scientists suggest halving the dose might reduce risks and help protect more people from COVID-19



Article feature image

By Kai Kupferschmidt, Gretchen VogelApr. 11, 2021 , 7:15 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
What was a worrisome suspicion four weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterized by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million who have received their first dose of the vaccine. More than 30 have died.

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
Airlines debunk rumours vaccinated travellers won’t be allowed to fly due to blood-clot fears – ABC News
Article feature image
Knowledge gaps on opioid use after surgery offer opportunities for improving patient education – EurekAlert